Prediction of overall survival in patients across solid tumors following atezolizumab treatments: A tumor growth inhibition–overall survival modeling framework

The objectives of the study were to use tumor size data from 10 phase II/III atezolizumab studies across five solid tumor types to estimate tumor growth inhibition (TGI) metrics and assess the impact of TGI metrics and baseline prognostic factors on overall survival (OS) for each tumor type. TGI met...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Phyllis, Marchand, Mathilde, Yoshida, Kenta, Vadhavkar, Shweta, Wang, Nina, Lin, Alyse, Wu, Benjamin, Ballinger, Marcus, Sternheim, Nitzan, Jin, Jin Y., Bruno, René
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520743/
https://www.ncbi.nlm.nih.gov/pubmed/34270868
http://dx.doi.org/10.1002/psp4.12686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520743/
https://www.ncbi.nlm.nih.gov/pubmed/34270868
http://dx.doi.org/10.1002/psp4.12686

Ejemplares similares